LAUSR

An elderly diabetic woman, presented from an outside institution with acute respiratory failure, complaining of headaches, fevers, and cough over several days. She was mildly neutropenic on admission with a slightly elevated ferritin level. The chest radiograph showed bilateral patchy opacities, and SARS-CoV-2 infection was confirmed by reverse transcription polymerase chain reaction. The clinical presentation also included the suggestion of right-sided mastoiditis supported by CT findings; she did not improve on aggressive antibiotic therapy with worsening leukocytosis and rising ferritin levels. Additional medications included apixaban, steroids, and insulin. Bone and gallium scintigraphy were requested to evaluate the extent of osseous and soft-tissue infection at the skull base [1]. Tc-MDP bone scan demonstrated increased right mastoid uptake; gallium scintigraphy performed at 48 h demonstrated overall normal biodistribution with focal intense mastoid uptake (planar, top transaxial images). Extensive typical COVID-19-related lung infiltrates were noted on SPECT/CT; more diffuse than on prior bone scintigraphy but associated with very minimal gallium activity (planar, lower transaxial images). The patient succumbed from COVID-19 complications 11 days following the gallium imaging. The finding of worsening COVID-19-related pneumonia with negligible gallium uptake contrasts with our observation of gallium’s effectiveness to identify mastoid bone suppuration and may relate to differences in pathogen (virus vs. bacteria), substrate (lung vs. bone), or nature of pathology (suppurative vs. ARDS-like process). Minimal lung uptake also strikingly differs from the relatively intense lung uptake reported with FDG [2–4]. Further exploration of differences in the molecular basis of gallium and FDG localization, and variation in the pathophysiology of mastoiditis and COVID-19related lung pathology, will help shed light on these observations. From a clinical perspective, while gallium scintigraphy is often regarded as a generally sensitive tool to identify infectious processes in the lungs [5], it appears that COVID-19related lung lesions may not be included in this blanket generalization.